Antimicrobial resistance (AMR) is a global health crisis, projected to cause up to 10 million deaths annually and impose economic costs exceeding $150 billion by 2050.

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Andrés ...

New OHE insight on immunisation: despite high returns on investment, global spending lags. We outline why and how countries ...

Pharmacogenomics (PGx) is the study of how genetic variation affects the efficacy and safety of medicines, enabling ...